Skip to main content

‘News’


WCNDD Collaboration that is impacting our understanding of dementia and Alzheimer’s Disease

Oct. 11, 2024—Take a look at how WCNDD is impacting our understanding of dementia and Alzheimer’s Disease, in collaboration with researchers at the University of Glasgow!

Read more


Congratulations to the WCNDD Director of Outreach and Edcuation, Kristen Gilliland

Oct. 11, 2024—Congratulations to the WCNDD Director of Outreach and Edcuation, Kristen Gilliland, for the production of the documentary “Speaking Through Me.” You can view the trailer here!

Read more


Warren Center for Neuroscience Drug Discovery names Craig Lindsley as Executive Director

Nov. 2, 2020—Craig Lindsley, the William K. Warren, Jr. Chair in Medicine and University Professor of Pharmacology, Biochemistry and Chemistry, will become director of Vanderbilt University’s Warren Center for Neuroscience Drug Discovery (WCNDD), effective Dec. 1, 2020. Lindsley assumes the director position from Jeffrey Conn, Lee. E. Limbird Chair in Pharmacology and professor of pharmacology. Founded by Conn in 2003...

Read more


Research News covers ACADIA Pharmaceuticals

Jun. 16, 2020—Research News @ Vanderbilt published an article about our collaboration with ACADIA Pharmaceuticals! Read the full article.

Read more


Research News covers Dr. Lindsley being named EIC

Jun. 12, 2020—Research News @ Vanderbilt published an article about Dr. Lindsley being named EIC for ACS Pharmacology and Translational Science! Read the full article.

Read more


ACS Axial does write up on Dr. Lindsley

Jun. 5, 2020—ACS Axial did a write up on Dr. Lindsley and ACS Pharmacology and Translational Science! Read the full article.

Read more


Dr. Lindsley the interim EIC for ACS Pharmacology and Translational Science

May. 27, 2020—In addition his role as EIC for ACS Chemical Neuroscience, Dr. Lindsley is now the interim EIC for ACS Pharmacology and Translational Science! ACS PTS is a great venue to publish your basic and translational pharmacology research (including clinical trials). The scope is broad (oncology, immunology, renal, cardiovascular, metabolic diseases and CNS – all areas and modalities are...

Read more


Dr. Lindsley interviewed by The Vanderbilt Hustler

May. 17, 2020—The Vanderbilt Hustler interviewed Dr. Lindsley regarding the Warren Funding! Read the full article.

Read more


Funding Awarded

May. 14, 2020—Congratulations to the SLO3: A Novel Contraceptive Target team (Celia M Santi Grau Perez MD, PhD, Jerod Denton, PhD, and Dr. Lindsley) for being awarded funding through the Washington University Leadership and Entrepreneurial Acceleration Program (LEAP)!

Read more